Artikel ; Online: Reducing MRSA Infection in a New NICU During the COVID-19 Pandemic.
2023 Band 151, Heft 2
Abstract: Background and objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in most NICUs, with a high rate of skin colonization and subsequent invasive infections among hospitalized neonates. The effectiveness of interventions designed ... ...
Abstract | Background and objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in most NICUs, with a high rate of skin colonization and subsequent invasive infections among hospitalized neonates. The effectiveness of interventions designed to reduce MRSA infection in the NICU during the coronavirus disease 2019 (COVID-19) pandemic has not been characterized. Methods: Using the Institute for Healthcare Improvement's Model for Improvement, we implemented several process-based infection prevention strategies to reduce invasive MRSA infections at our level IV NICU over 24 months. The outcome measure of invasive MRSA infections was tracked monthly utilizing control charts. Process measures focused on environmental disinfection and hospital personnel hygiene were also tracked monthly. The COVID-19 pandemic was an unexpected variable during the implementation of our project. The pandemic led to restricted visitation and heightened staff awareness of the importance of hand hygiene and proper use of personal protective equipment, as well as supply chain shortages, which may have influenced our outcome measure. Results: Invasive MRSA infections were reduced from 0.131 to 0 per 1000 patient days during the initiative. This positive shift was sustained for 30 months, along with a delayed decrease in MRSA colonization rates. Several policy and practice changes regarding personnel hygiene and environmental cleaning likely contributed to this reduction. Conclusions: Implementation of a multidisciplinary quality improvement initiative aimed at infection prevention strategies led to a significant decrease in invasive MRSA infections in the setting of the COVID-19 pandemic. |
---|---|
Mesh-Begriff(e) | Infant, Newborn ; Humans ; Methicillin-Resistant Staphylococcus aureus ; Cross Infection/prevention & control ; Cross Infection/epidemiology ; Intensive Care Units, Neonatal ; Staphylococcal Infections/epidemiology ; Staphylococcal Infections/prevention & control ; Pandemics/prevention & control ; Infection Control ; COVID-19/prevention & control |
Sprache | Englisch |
Erscheinungsdatum | 2023-01-10 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article |
ZDB-ID | 207677-9 |
ISSN | 1098-4275 ; 0031-4005 |
ISSN (online) | 1098-4275 |
ISSN | 0031-4005 |
DOI | 10.1542/peds.2022-057033 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Um IV Zs.131: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 357: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.